HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab

Clinical trial NCT00349349 · COMPLETED

Trial details

NCT number: NCT00349349
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukaemia, Lymphocytic, Chronic

Start date: 2006-06-01
Primary completion: 2008-05-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.